This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Champions Oncology (NASDAQ:CSBR)CurrentInstitutional OwnershipPercentage41.30%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$1.68MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.70M Get CSBR Insider Trade Alerts Want to know when executives and insiders are buying or selling Champions Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CSBR Institutional Buying and Selling by Quarter Champions Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025 Acadian Asset Management LLC39,511$341K0.0%+28.7%0.286% 5/19/2025 Jane Street Group LLC23,020$200K0.0%N/A0.167% 5/16/2025 Goldman Sachs Group Inc.23,129$201K0.0%N/A0.167% 5/15/2025 OMERS ADMINISTRATION Corp10,700$93K0.0%N/A0.077% 5/13/2025 Tocqueville Asset Management L.P.399,882$3.47M0.1%-34.3%2.894% 5/13/2025 Informed Momentum Co LLC79,987$694K0.1%N/A0.579% 5/13/2025 HighTower Advisors LLC35,158$305K0.0%-10.6%0.254% 2/14/2025 Northern Trust Corp53,994$463K0.0%+31.5%0.391% 2/13/2025 Renaissance Technologies LLC138,839$1.19M0.0%+15.7%1.005% 2/12/2025 Geode Capital Management LLC66,511$570K0.0%+2.2%0.481% Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/11/2025 Virtu Financial LLC11,051$95K0.0%N/A0.080% 2/10/2025 Tocqueville Asset Management L.P.608,915$5.22M0.1%-13.7%4.406% 11/15/2024 HighTower Advisors LLC39,308$191K0.0%+14.6%0.289% 4/26/2024 Mesirow Financial Investment Management Inc.12,380$61K0.0%N/A0.091% 2/13/2024 Aristides Capital LLC11,822$66K0.0%-45.3%0.087% 2/8/2024 Essex Investment Management Co. LLC77,200$434K0.1%-26.7%0.568% 11/9/2023 Essex Investment Management Co. LLC105,335$654K0.1%-5.4%0.781% 5/15/2023 Overbrook Management Corp48,488$195K0.1%-10.0%0.358% 5/10/2023 Tocqueville Asset Management L.P.665,428$2.68M0.1%+8.2%4.907% 2/9/2023 Tocqueville Asset Management L.P.615,228$2.78M0.1%+80.1%4.537% 11/15/2022 Essex Investment Management Co. LLC107,711$808K0.1%-6.4%0.797% 11/14/2022Ergoteles LLC13,937$105K0.0%N/A0.103% 10/31/2022Millrace Asset Group Inc.346,976$2.60M3.3%-2.0%2.566% 7/28/2022Millrace Asset Group Inc.354,041$2.83M2.7%+7.6%2.619% 5/9/2022 Essex Investment Management Co. LLC115,075$936K0.1%+8.1%0.851% 2/10/2022 Essex Investment Management Co. LLC106,423$890K0.1%+18.9%0.787% 2/3/2022ACT Capital Management LLC62,500$523K0.4%+6.8%0.462% 11/16/2021ACT Capital L.L.C.58,500$597K0.3%+17.0%0.436% 11/15/2021 Dimensional Fund Advisors LP119,902$1.22M0.0%-8.2%0.893% 11/15/2021 HighTower Advisors LLC26,467$270K0.0%+36.2%0.197% 11/12/2021 Renaissance Technologies LLC221,146$2.26M0.0%-3.0%1.648% 11/9/2021 Essex Investment Management Co. LLC89,507$914K0.1%-1.8%0.667% 11/9/2021BlackRock Inc.122,398$1.25M0.0%+14.4%0.912% 8/17/2021 Millennium Management LLC88,310$908K0.0%N/A0.658% 8/16/2021 State Street Corp24,163$248K0.0%-76.2%0.180% 8/13/2021 Northern Trust Corp27,719$285K0.0%-68.8%0.207% 8/13/2021 Overbrook Management Corp94,940$976K0.2%-1.8%0.708% 8/13/2021 Geode Capital Management LLC42,953$441K0.0%-53.7%0.320% 8/13/2021 Vanguard Group Inc.327,636$3.37M0.0%-29.5%2.442% 8/12/2021 Dimensional Fund Advisors LP130,655$1.34M0.0%+1.8%0.974% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a8/12/2021 JPMorgan Chase & Co.4,379$45K0.0%-78.4%0.033% 8/12/2021 Bank of Montreal Can102,934$1.09M0.0%+39.1%0.767% 8/12/2021Ergoteles LLC30,900$318K0.0%N/A0.230% 8/11/2021Millrace Asset Group Inc.280,439$2.88M1.5%+7.8%2.090% 8/11/2021 Bank of New York Mellon Corp51,825$533K0.0%-24.1%0.386% 8/11/2021 Susquehanna Fundamental Investments LLC28,382$292K0.0%N/A0.212% 7/31/2021 Roubaix Capital LLC351,507$3.61M2.3%+25.9%2.621% 5/18/2021 California State Teachers Retirement System9,731$110K0.0%-10.6%0.073% 5/17/2021 Aristides Capital LLC36,750$415K0.2%-8.1%0.274% 5/14/2021 Dimensional Fund Advisors LP128,293$1.45M0.0%-2.4%0.958% 5/13/2021ClariVest Asset Management LLC56,600$640K0.0%+5.6%0.423% 5/13/2021 Barclays PLC5,658$64K0.0%+171.8%0.042% 5/13/2021 Renaissance Technologies LLC228,433$2.58M0.0%+3.0%1.706% 5/13/2021 Bank of Montreal Can74,012$842K0.0%-22.8%0.553% 5/12/2021 Northern Trust Corp88,943$1.01M0.0%-17.1%0.664% 5/12/2021 JPMorgan Chase & Co.20,287$229K0.0%+7.8%0.152% 5/12/2021 UBS Group AG2,553$29K0.0%+165.7%0.019% 5/7/2021BlackRock Inc.470,447$5.32M0.0%+1.1%3.513% (Data available from 1/1/2016 forward) CSBR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CSBR shares? During the previous two years, 14 institutional investors and hedge funds held shares of Champions Oncology. The most heavily invested institutionals were Tocqueville Asset Management L.P. ($3.47M), Renaissance Technologies LLC ($1.19M), Informed Momentum Co LLC ($694K), Geode Capital Management LLC ($570K), Northern Trust Corp ($463K), Essex Investment Management Co. LLC ($434K), and Acadian Asset Management LLC ($341K).Learn more on Champions Oncology's institutional investors. What percentage of Champions Oncology's stock is owned by institutional investors? 41.30% of Champions Oncology's stock is owned by institutional investors. Learn more on CSBR's institutional investor holdings. Which institutional investors have been buying Champions Oncology's stock? Of the 11 institutional investors that purchased Champions Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Informed Momentum Co LLC ($79.99K), Goldman Sachs Group Inc. ($23.13K), Jane Street Group LLC ($23.02K), Renaissance Technologies LLC ($18.85K), Northern Trust Corp ($12.92K), Mesirow Financial Investment Management Inc. ($12.38K), and Virtu Financial LLC ($11.05K). How much institutional buying is happening at Champions Oncology? Institutional investors have bought a total of 194,919 shares in the last 24 months. This purchase volume represents approximately $1.68M in transactions. Which of Champions Oncology's major shareholders have been selling company stock? The following institutional investors have sold Champions Oncology stock in the last 24 months: Tocqueville Asset Management L.P. ($305.33K), and HighTower Advisors LLC ($4.15K). How much institutional selling is happening at Champions Oncology? Institutional investors have sold a total of 309,482 shares in the last 24 months. This volume of shares sold represents approximately $2.70M in transactions. Related Companies MYGN Institutional Ownership MREO Institutional Ownership CGEM Institutional Ownership AMLX Institutional Ownership TALK Institutional Ownership AXGN Institutional Ownership CELC Institutional Ownership ORKA Institutional Ownership SIGA Institutional Ownership CMPS Institutional Ownership This page (NASDAQ:CSBR) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored"I'm risking my reputation on this"Crypto book predicted the last bull run (get it FREE now) This newly updated edition contains everything we...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.